Effect of Dual-Targeted Therapy Combined with Paclitaxel and Carboplatin as Neoadjuvant Treatment for Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer

doi:10.3969/j.issn.2096-3327.2026.08.006

XIE YI, ZHANG De-zhi, LIU Xu-hui, HAN Zhi-wei, ZHAO Yu-peng, YANG Lu-li

Chinese Journal of Rational Drug Use ›› 2026, Vol. 23 ›› Issue (8) : 35-42.

PDF(2551 KB)

Chinese Journal of Rational Drug Use ›› 2026, Vol. 23 ›› Issue (8) : 35-42. DOI: 10.3969/j.issn.2096-3327.2026.08.006

Cancer Medication

Effect of Dual-Targeted Therapy Combined with Paclitaxel and Carboplatin as Neoadjuvant Treatment for Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2026, 23(8): 35-42 https://doi.org/10.3969/j.issn.2096-3327.2026.08.006

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

Funding

RIGHTS & PERMISSIONS

PDF(2551 KB)

Accesses

Citation

Detail

Sections

Recommended

Please choose a citation manager

Content to export